Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Hughes Institute team describes research into platinum complexes

Dec. 8, 1999

CRCT discloses new cyclopropylindoles for ADEPT and/or GDEPT of cancer

Dec. 8, 1999

Select Therapeutics extends agreement with Institut Curie for cancer vaccine

Dec. 8, 1999

Calphostin C tested as photodynamic therapy in bladder cancer cell lines

Dec. 8, 1999

New platinum analogue assessed in advanced gastric cancer patients

Dec. 8, 1999

Hughes Institute's COBRA compounds target a novel tubulin binding site

Dec. 7, 1999

Very promising clinical trial results achieved with leukemia treatment

Dec. 7, 1999

In vivo antiangiogenic activity described for FMPA

Dec. 7, 1999

ImClone and Merck KGaA initiate first international phase III trial center of C225

Dec. 6, 1999

Maret initiates clinical development of MARstem for chemotherapy-induced neutropenia

Dec. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...